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As of June 2016 there are 28 medical schools [1] in 
both private and public sectors in Malaysia offering 
more than twice as many programs [2] with yearly 
graduates of about 4500 including those that graduated 
from overseas. This magnitude is beyond the usual 
capacity of Ministry of Health (MOH) that is entrusted 
to accord preregistration training posts to the graduates 
as the whole process of allocation to available places in 
public hospitals nationwide is painfully slow. It is 
already a tragedy having to wait 6 months on average 
for a placement but words that a delay for up to a year 
can occur is totally unacceptable when the actual 
training places available at grade DU41 preregistration 
house officers is said to be more than the graduate 
number [3]. Delay can be detrimental to the training 
itself because waiting is a waste of talent and potential, 
a disincentive to a young aspirant, tacitly is a testimony 
of system failure and deprives the public of highly 
trained graduates to serve in our healthcare system that 
ironically suffers from chronic and ever growing wait 
but yet we have excess medical graduates. Some of 
them have taken a simple and quick route out of the 
mess by migrating to our neighbours near and far, not 
entirely their faults, but their thresholds to despair seem 
very low indeed. The need for a speedy and right 
solution to the delay is long overdue and this is nothing 
more than what the public and the young doctors 
deserve. 
  How did we get to this? Not unexpectedly but 
the magnitude stemmed from the unusually large 
number of Sijil Pelajaran Malaysia (SPM; Malaysia 
Certificate of Education) leavers that opted to study 
medicine, in part made easy by the many medical 
schools in the country and those that have been 
accredited abroad. This was augmented by the constant 
reminder of the need for more doctors, parental or hype 
pressure perhaps for whatever reasons, and also the ease 
with which scholarships were available to study 
medicine. The principle driver for the whole mess was 
money initiated by those who wish to make profits 
under these “fortunate” circumstances [4]. The resulting 
deluge of medical graduates clogged the system up and 
unfortunately created many of the unnecessary 
challenges that we face today. Paradoxically despite 
this excess our doctor population ratio is still lower than 
the Organization for Economic Cooperation and 
Development (OECD) average and our more 
prosperous neighbour in the south. These veiled and 
unscrupulous drivers are addressing the gap in ratio 
with such a speed that it strains the system to almost 
breaking point and had somewhat ruffled both Ministry 
of Higher Education (MOHE) and MOH. 
  The doctor number that we need should ideally 
be planned or rather managed at this point and this can 
only be done by addressing all the factors that had led 
us to this. For a start we should look at the basic 
question of what the country needs in the future (2020 
and beyond) and then work backwards. This sounds 
simple enough but in practice this is where the 
challenge lies. Two ministries MOH and MOHE are 
both looking at the issue albeit with different focus but 
inevitably with some overlapping jurisdiction. The 
MOH concerns with the nation’s health issues and 
MOHE deals with medical education and consequently 
doctor number, although seemingly separate but in 
actual fact they will converge. Whatever the number of 
medical students approved at Malaysian Qualifications 
Agency (MQA) / Malaysian Medical Council (MMC) 
or sponsored by Jabatan Perkhidmatan Awan (JPA; 
Public Services Department) /MOHE the final tally in 
five years will be the medical graduates that will have 
to be allocated to training places. Too many medical 
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graduates too soon appear to be the main problem and 
therefore it is high time that we try to regulate the 
number that goes into training. Immediate actions are 
required too to restore public confidence in the light of 
unsympathetic media comments. This includes policies 
that require hard choices such as derecognizing some 
foreign medical schools in the archaic list of schedule 2 
and introducing the right to practice examination for 
those who have graduated from abroad. Both can 
regulate number and consequently emphasize quality. 
  The next challenge is the specialist number 
now that doctor number at lower grades will address the 
gap in ratio in time. Although a lot has improved but by 
most estimates the number of specialists must double to 
take up the challenges of a developed nation status and 
we need to add to this the question of disparity (uneven 
number by specialty) and geographical mal-distribution, 
unfortunately the issues remain despite numerous 
incentives introduced by MOH over the years. An 
easier question of churning up specialist number can be 
addressed rather immediately because we have a robust, 
economical, and internationally respected system within 
our midst that is the Master in Medicine (MMED). But 
when the issue of increasing the specialist number is 
debated, the discourse mystically takes a pathetic 
course to the times when postgraduate medicine began 
in the country in the 60s, a return to our colonial 
ancestry for training opportunities and supervision. 
When postgraduate medicine first started we indeed 
relied heavily on the hospitals in the United Kingdom 
(UK) and their college exams but these are things of the 
past. Except for stated and specific niche areas for 
training and education, or occasional exception, by and 
large we have existed and trained our specialist 
independently from the system in the UK for more than 
three decades. For the record, to date more than 8000 
specialists have graduated from MMED system and for 
a rapidly growing Malaysia this number is huge. 
Especially so for the surgical based specialties that are 
the most challenging to train and in all domains the 
surgeons have been at par with the very best in the 
world. In fact from our own survey, MMED trained 
specialists are the backbone of doctors that service the 
public hospitals and clinics in Malaysia. 
 
  Despite this apparent regression, the 
universities that offer MMED are in the process of 
institutionalizing the training pathway and system to 
maintain the quality and improve the process further. 
Steps are taken to formalize the training pathway via 
MQA and MOHE to reinforce public perception of the 
system and in preparation for soon to be implemented 
trade and economic liberalization in ASEAN. For 
practical purposes the MMED system essentially has 
two types; one that is based on the presence of the 
faculty’s own teaching hospital and the other on the 
absence of one and thus reliance on the state hospital as 
the faculty’s affiliated teaching hospital. Both models 
have achieved success and maintained the quality and 
competency required by a robust comprehensive 
assessment system that includes standardized 
examinations attended by a wide selection of examiners 
in the country and abroad. In the next 5 years or so, the 
training environment to some extent the MMED will 
undergo a significant change with the completion of 
another 7 teaching hospitals and the incorporation of a 
consortium of university teaching hospitals. With an 
estimated number of nearly 10000 tertiary care beds at 
peak activity this will provide an excellent opportunity 
to train more specialists and partake in subspecialty 
training. This includes research and teaching activities 
that will enhance the return on investment to the public. 
  Based on the cumulative years of experience 
and a much more organized MQA the future of medical 
education for both undergraduate and postgraduate 
looks very promising indeed but the main lingering 
issues in both must be addressed. For undergraduate 
medicine the need to maintain a robust and stringent 
control on quality is paramount and data shows that the 
emphasis of this is mainly on graduates from some 
foreign medical schools because the local ones are 
subject to very stringent accreditation exercise and 
compliance audit, therefore quality is assured. Another 
strategy to achieve this is the introduction of fitness to 
practice examination for foreign medical school 
graduates. Both will help control number. The main 
issue that is affecting postgraduate education is the need 
to institutionalize the MMED for the future and the 
creation of teaching hospitals consortium by working 
closely with MQA and MOHE. This will ensure the 
best deal for the public. The future is in our hands. 
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INTRODUCTION 
Allergic rhinitis represents a global health problem. It 
is estimated that about 20-40 million people are 
affected in the US. The prevalence of allergic rihitis in 
other countries ranges from 3% to 19% [1]. In 
Kelantan, Malaysia, the prevalence was 27% amongst 
school children; was being more prominent in the  12-
14 year age group (38.2%) compared to 5-7 year age 
group (18.2%) [2]. The disease is a long standing 
disease and may affect patients’ quality of life 
considerably. Because of this, it can affect the cost of 
the treatment as a whole. The estimated cost of allergic 
rhinitis is 2.7 billion dollars for the year 1995, 
excluding costs for associated medical problems such 
as sinusitis and asthma [3]. 
 Many classes of drug are available for the 
treatment of allergic rhinitis. Intranasal corticosteroids, 
have a good safety profile with fast rate of symptoms 
reduction. However incorrect use leads to treatment 
failure or adverse events such as epistaxis in 10-15% 
of patients. First-generation antihistamines are 
associated with sedation, psychomotor retardation and 
reduced academic performance. Even with the 
pharmacotherapy, one in five affected individuals 
remains highly symptomatic, and therefore further 
research is needed in this area [4].
 
 Currently, alternative medicine is increasingly 
employed to treat diseases which have no cure in 
modern medicine or which have risks of side effects.  
Virgin coconut oil (VCO) is well known as a 
nutraceutical. VCO is promoted as a supplementary 
diet due to its beneficial effects on various health 
problems. A lot of testimonials about its benefit have 
been reported in many web publications. However, 
there is scant published data in scientific journals. For 
this reason many researchers would like to conduct a 
study to determine its therapeutic effects.  
 VCO is obtained by wet processing which 
involves extraction of cream from the fresh coconut 
milk and subsequently breaking the cream emulsion 
[5]. In contrast to commercial coconut oil or also 
known as Refined, Bleached and Deodorized (RBD) 
coconut oil the refining process to make the oil edible 
will render it to oxidative rancidity and contamination 
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with aflatoxin, and will cause loss of its active 
biological substances [6]. VCO was able to attract 
interest from the community since its first appearance 
in the market and became popular due to its perceived 
therapeutic values, availability and cheaper cost as an 
alternative treatment [5]. If VCO is proven to have 
beneficial effects towards allergic rhinitis, then it will 
helps to reduce the financial burden in the treatment 
since it also has other beneficial effects for instance 
reduction of total cholesterol, triglycerides, 
phospholipids and low density lipoprotein [7]. 
 The aim of this study is to determine the 
efficacy and side effects of virgin coconut oil as an 
adjunct to the conventional treatment with 
antihistamine and topical steroid and compare it with 
treatment using antihistamine and topical steroid alone 
on the basis of symptoms score.  
 
METHODS 
Study Design 
This open label, randomized, parallel-group controlled 
clinical trial was conducted over the period of two 
years. The subjects were recruited patients attending 
the Otorhinolaryngology clinic,  Universiti Sains 
Malaysia (USM), Kubang Kerian. Patients aged 18 to 
50 years old who were diagnosed clinically to have 
allergic rhinitis and had consented for skin prick test 
were invited to participate in the study. Patients who 
were diabetic, pregnant or with evidence of 
rhinosinusitis were not included in the study. Those 
who were allergic to coconut oil or coconut oil based 
product were also not included. 
 Each subject who agreed to participate in the 
study was asked to answer questionnaires at the 
beginning of the study to assess their symptoms score. 
The questionnaires were asked in Malay. The initial 
symptoms score would be the baseline reading to be 
compared with symptoms score post treatment. Seven 
symptoms were assessed in the symptom score, which 
include nasal blockage, nasal discharge, sneezing, 
nasal, eye and palate itchiness and hyposmia. The 
symptom score was based on 7-point visual analog 
scale, published by the Joint Task Force on Practice 
Parameters on Allergy, Asthma, and Immunology [8]. 
Eligible patients were recruited either in test or control 
group. The allocation of participants into test or 
control group was done using systematic random 
sampling using random table. The enrolment into the 
study and allocation into the group were done by a 
research assistant. A total of 26 patients were allocated 
in each group of test subject and control (Figure 1). 
The sample size was calculated using PS: Power and 
Sample Size Calculation software version 3.0. 
 
Figure 1 Participant Flow Diagram 
 
Participants in test group were given 10 ml virgin 
coconut oil orally three times per day and 
antihistamine (loratadine) for 28 days. VCO was 
prepared in small packs, which consists of 10ml per 
pack. Each patient was given 84 packs of VCO. The 
virgin coconut oil was taken with meal or separately, 
but each participant was instructed not to use it during 
food preparation for instance cooking at high 
temperatures. The control group was treated with 
10mg loratadine once daily. All participants were 
reassessed after 28 days of treatment to determine their 
symptoms score. The research assistant followed up 
with the participants through a telephone call for next 
appointment after completion of treatment. After 14 
days, the same research assistant will make a telephone 
call to monitor progress of treatment and 
complications or side effects from treatment. After 28 
days of treatment, participant in the test group should 
finish all VCO given. The participants who still have 
few packs left, were considered as non-compliants. 
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The results of symptoms score were compared pre and 
post treatment. The complications or side effects from 
the treatment, if any, were assessed after 28 days. The 
same research assistant asked and marked the scoring 
at all times. The data were analysed using SPSS 
software version 18 to an 80% power of study. 
 
Skin Prick Test Protocol 
Skin prick test was done (ALK-Abello skin prick test 
kit, Bege Alle, 2970 Horsholm, Denmark) for the 
common allergens found to be positive in Kelantan 
area based on data from immunology department in 
USM, for examples Dermatophagoides pteronyssinus, 
Dermatophagoides farina, Blomia tropicalis, Felis 
domesticus and shrimp. Skin prick test was done by 
the same research assistant. During the skin prick test, 
histamine was used as the positive control and 
physiologic saline was used as negative control. 
Fifteen minutes were allowed for the reactions to 
ensue. The presence of a wheel with a diameter of 3 
mm or more is considered a positive reaction [9]. 
 
RESULTS 
A total of 52 participants (26 in each test and control 
group) were enrolled into the study. There was no 
dropout in the study. 
 
Table 1 Age distribution in control and test group  
Group  Age  Frequency 
 
Percentage 
(%) 
 
Control Group  
 
Below 20  5 19.2 
21 - 25  3 11.5 
26 - 30  9 34.6 
31 - 35  5 19.2 
36 and above  4 15.4 
Total  26 100 
Test Group  
Below 20  0 0 
21 - 25  7 26.9 
26 - 30  5 19.2 
31 – 35 4 15.4 
36 and above  10 38.5 
 Total 26 100 
 
 In test group the highest age group was 36 
years and above (38.5%), followed by 21 to 25 years 
(26.9%), 26 to 30 years (19.2%) and lastly 31 to 35 
years (15.4%). However in control group the majority 
of subjects were within 26 to 30 years (34.6%), 
followed by 18 to 20 years and 31 to 35 years in same 
proportion (19.2%), 36 and above (15.4%) and 21 to 
25 years (11.5%) (Table 1). 
 
 
Figure 2 Gender distribution among control and test group  
 
 In this study, male and female subjects were 
equally allocated in test group. However, there is slight 
increase in the number of female subjects (53.8%) as 
compared to male (46.2%) in control group. Based on 
gender distribution, there is no significant difference 
between male and female in control group. (Figure 2) 
 
 
Figure 3  Racial distribution in both control and test group  
 
 Participants in this study were predominantly 
Malays (80.8%), followed by Chinese (9.6%) and 
Indians (9.6%) (Figure 3). 
 
Figure 4  Frequency of skin prick test in control group  
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 The majority of participants in control group 
were positive for house dust mite (Dermatophagoides 
pteronyssinus and Blomia tropicalis); the highest was 
Dermatophagoides pteronyssinus 100%, followed by 
Blomia tropicalis 96.2%. The third most common 
allergen was to Felis domesticus 30.8%, followed by 
shrimp 26.9% and the least Dermatophagoides farinae 
11.5% (Figure 4). In test group, most of the 
participants were positive for house dust mite; 
Dermatophagoides pteronyssinus 96.2%, Blomia 
tropicalis 92.3% and Dermatophagoides farinae 
92.3%, followed by shrimp 57.7% and Felis 
domesticus 42.3% (Figure 5). 
 
Figure 5 Frequency of skin prick test in test group 
 
Nasal Symptoms Score 
When Nasal Symptom Score were compared between 
test and control groups, there were no significant 
difference in symptoms of nasal blockage, discharge 
and itchiness. However, sneezing score showed a 
significant difference (p <0.05) (Table 2). Mean 
difference in sneezing symptoms score in control 
group between pre and post treatment is -2.69, while in 
test group is -1.65. This showed that the difference in 
sneezing symptoms score was more in control group as 
compared to test group (Table 3). 
 
Table 2 Mean difference of nasal symptom score between initial and end of  
the study for a given period calculated using t-test 
Nasal 
Symptom 
Mean 
Difference 
p-
value 
Standard 
error 
difference 
95% CI of the 
difference 
Lower    Upper 
Blockage 0.538 0.244 0.457 -1.456     0.379 
Discharge 0.087 0.876 0.492 -0.912     1.066 
Itchiness 0.538 0.285 0.498 -1.539     0.462 
Sneezing 0.538 0.033 0.498 -1.539     0.462 
 
 
Table 3 Mean difference of nasal symptoms score in control and test group  
between pre and post treatment calculated using t-test 
Symptoms Group N Mean Standard 
deviation 
Blockage 
difference 
Control 
Test 
26 -2.15 
-1.62 
1.377 
1.878 
Discharge 
difference 
Control 
Test 
26 -1.88 
-1.96 
1.681 
1.865 
Itchiness 
difference 
Control 
Test 
26 -1.58 
-1.04 
1.362 
2.144 
Sneezing 
difference 
Control 
Test 
26 -2.69 
-1.65 
1.806 
1.599 
 
Non Nasal Symptoms Score 
Table 4 Mean difference of non-nasal symptoms score in control and test 
group between pre and post treatment calculated using t-test 
Symptoms Group N Mean Standard 
deviation 
Smell difference Control 
Test 
26 
26 
-1.42 
-0.65 
1.419 
1.958 
Eye itchiness 
difference 
Control 
Test 
26 
26 
-1.23 
-1.62 
0.951 
2.699 
Palate itchiness 
difference 
Control 
Test 
26 
26 
-0.46 
-0.81 
1.067 
1.132 
Symptoms in 
general 
Control 
Test 
26 
26 
-2.58 
-1.69 
1.362 
1.914 
 
Table 5 Mean difference in non-nasal symptom score between initial and 
end of the study for a given period calculated using t-test 
Non-nasal 
symptom 
Mean 
difference 
p-
value 
Standard 
error of 
difference 
95% CI of the 
difference 
Lower     Upper 
Smell 0.769 0.111 0.498 -1.722     0.183 
Eye itchiness 0.385 0.496 0.561 -0.743     1.512 
Palate 
itchiness 
0.346 0.262 0.305 -0.267     0.959 
 
Side Effects of Virgin Coconut Oil 
Approximately 15 subjects in this study (58%) 
developed gastrointestinal tract side effects, for 
instance abdominal bloatedness, oily stool, nausea and 
oily taste in throat. Two subjects (7.7%) complained of 
headache and palpitation. Most of the side effects 
reported were temporary and resolved spontaneously. 
Most of the subjects who experienced side effects took 
VCO without meals. Only 9 subjects (34.6%) did not 
have any complain when consuming virgin coconut oil 
and most of them took virgin coconut oil with meals 
(Figure 6). 
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Figure 6 Side effects after consumption of virgin coconut oil in a test 
group. GIT – gastrointestinal side effects 
 
DISCUSSION 
General principles in the clinical management of 
allergic rhinitis include: avoidance of triggering factors 
or allergens, pharmacotherapy, patient education and 
follow up [10]. The aims of pharmacotherapy are to 
control symptoms, prevent sequel and improve 
patient’s quality of life [11]. Often, treatment using 
combination drugs offer better relief as compared to 
single therapy. This is due to involvement of several 
mediators in the pathophysiology of allergic rhinitis. 
This preliminary study aims to determine the effect of 
virgin coconut oil in the treatment of allergic rhinitis, 
and if the result is significant, the molecular 
mechanisms can be studied. To the best of our 
knowledge, there is no previous study to assess the 
effect of virgin coconut oil (VCO) on allergic rhinitis. 
However, only testimonials have been produced so far. 
 In this study, we compared the mean 
difference for nasal symptom score between control 
and test groups. For all symptoms except sneezing, the 
results showed no statistically significant difference 
between control and test groups. However, the 
sneezing score was significantly different between 
control and test groups with p-value 0.033 (< 0.05). 
However, when the mean differences in sneezing score 
were compared between pre and post treatment in 
control (-2.69) and test (-1.65) groups, the results 
showed that the control group had larger sneezing 
score difference between pre and post treatment. This 
implied that sneezing score was reduced in control 
group than test group after completion of treatment. It 
is unusual to have better improvement in symptom 
score in control group as compared to the test group. 
The above results showed that virgin coconut oil has 
no beneficial effect on nasal symptom score and only 
has side effects especially involving gastrointestinal 
tracts. We presumed that because of the side effects, 
the amounts of the VCO taken maybe reduced and its 
compliance maybe affected as well. Furthermore, 
when the subjects developed gastrointestinal side 
effects, they may forget to take loratadine. This could 
probably affect the results of nasal symptom score in 
the test group. 
 We also compared the mean difference for 
non-nasal symptom score between control group and 
test group. For all symptoms, i.e smell, eye itchiness, 
palate itchiness and symptoms in general score there is 
no statistically significant difference between control 
and test groups. This result also showed that short term 
use of virgin coconut oil 30 ml per day has no effect 
on non-nasal symptom score of allergic rhinitis. 
 In our study, more than half of the total 
subjects in test group reported adverse effects from 
consumption of virgin coconut oil throughout the 
study period. About 50% of them complained of 
gastrointestinal side effects, such as abdominal 
bloatedness, oily stool, nausea and oily taste in throat.  
A small number of the subjects (7.7%) complained of 
headache and palpitation. However, all the symptoms 
were mild and tolerable. Only 9 out of 26 subjects 
(34.6%) did not have any adverse reaction and on 
further questioning, most of them took VCO with 
food. In a study conducted by Cecille in 2010, about 
twenty participants complained of gastrointestinal side 
effects [12]. The findings of gastrointestinal effects in 
this present study are consistent with the acute 
toxidrome syndrome of VCO intake seen in rats which 
consisted of blood-streaked feces and oily mucoid 
stool [13]. Therefore in our study, the side effects 
experienced by most of our subjects most likely come 
from the virgin coconut oil and not because of other 
foods that they took. 
 Flavonoids are the most biologically active 
phenolic substances found in VCO. Initially we 
postulated that its phenolic content might be attributed 
to the high antioxidant and antiallergic acitivity [5]. 
Flavonoids not only inhibit histamine release, but also 
inhibit synthesis of IL-4 and IL-13 and CD40 ligand 
expression by basophils [14]. 
 A number of studies have reported promising 
results of flavonoid towards allergy. An unpublished 
preliminary study to assess effect of persimmon leaf 
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extract, which contain flavonoid on atopic dermatitis, 
was attempted by Takigawa and showed significant 
improvement. An animal study was also done on mice 
to evaluate its effect on improvement of dermatitis. 
The results showed that flavonoid in persimmons leaf 
extract significantly reduced the severity of dermatitis, 
scratching behaviour and transepidermal water loss 
even after onset [15]. A 30-year longitudinal 
epidemiological study reported that incidence of 
allergic related diseases was lower in populations with 
higher intake of flavonoids [16]. 
 Despite many studies showed promising 
results of flavonoid toward improvement of allergy 
symptoms, this present study showed contradictory 
results. We assume based on the clinical assessment, 
which can be subjective that the amount of virgin 
coconut oil for daily intake, patient compliance to 
treatment and the preparation of virgin coconut oil 
may affect the results post treatment. Nevertheless, the 
combination of clinical judgement from nasal 
symptom score and objective assessment for instance 
serial serum specific IgE will be more useful to 
determine effects of VCO on allergic rhinitis. 
 Since the amount of virgin coconut oil to be 
consumed has not been standardized, we used the 
amount based on the previous studies to assess for 
other parameters, which showed good results on their 
subjects. 
 In the present study, the participants can take 
the virgin coconut oil without food or by mixing it 
with food or drink as recommended by manufacturers, 
but not during food preparation, for instance cooking. 
We presumed that when mixing the virgin coconut oil 
with food or drink, some amount of the virgin coconut 
oil might be left in the plate or glass after meal, which 
make the total dose of virgin coconut oil inadequate 
and inconsistent throughout the period of study. 
Furthermore, the results of subjects who take the VCO 
with food will probably differ with those taking it 
separately. When we compared the method of 
consumption of VCO to the subjects with other 
studies, for example a study by Monica in 2009, the 
coconut oil were taken by the test subject with 
preparation of food, and yet still revealed promising 
results [17]. In contrast to a study done by Cecille in 
2010, the participants were instructed to consume 
virgin coconut oil three times a day before each main 
meal, and at the end of treatment period, the study has 
produced contradictory results [12]. 
 
Limitations and Recommendations 
The findings in this study should be considered as 
preliminary, as there are several limitations of this 
study. First the sample size of subjects in this study is 
relatively small and may not truly represent the whole 
population. So a multicentered, larger randomized 
controlled trial is needed to provide further evidence 
and validate the results. Second, severity and response 
towards treatment were only based on clinical criteria, 
i.e symptoms score. Even though we used validated 
symptoms score and employed a single research 
assistant for scoring assessment throughout the study 
to limit the potential bias, however an immunological 
test for instance serum specific IgE would be more 
objective. Due to limited budget, the assessment was 
based on only symptoms score. Third the amount or 
dosage of VCO used in this study was not the standard 
dose. The amount used in this study was based on the 
study by Monica in 2009 [17], 30ml a day. The VCO 
used is not a standardized commercially manufactured 
coconut oil. Therefore the results are only applicable to 
the batches of VCO used here. Work is currently under 
way to study the effects of VCO active compound, 
flavonoid on the mechanism of allergic rhinitis using 
objective molecular analysis.  
 
CONCLUSIONS 
This study showed that consumption of virgin coconut 
oil as an adjunct treatment of allergic rhinitis has no 
significant effect towards improvement of allergic 
rhinitis symptoms based on symptom score. 
Furthermore, it has side effects, which may affect 
patients’ compliance. 
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